Current status of biomarker research in neurology

11Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

© 2016 The Author(s).Neurology is one of the typical disciplines where personalized medicine has been recently becoming an important part of clinical practice. In this article, the brief overview and a number of examples of the use of biomarkers and personalized medicine in neurology are described. The various issues in neurology are described in relation to the personalized medicine and diagnostic, prognostic as well as predictive blood and cerebrospinal fluid biomarkers. Such neurological domains discussed in this work are neuro-oncology and primary brain tumors glioblastoma and oligodendroglioma, cerebrovascular diseases focusing on stroke, neurodegenerative disorders especially Alzheimer's and Parkinson's diseases and demyelinating diseases such as multiple sclerosis. Actual state of the art and future perspectives in diagnostics and personalized treatment in diverse domains of neurology are given.

Cite

CITATION STYLE

APA

Polivka, J., Krakorova, K., Peterka, M., & Topolcan, O. (2016, July 4). Current status of biomarker research in neurology. EPMA Journal. BioMed Central Ltd. https://doi.org/10.1186/s13167-016-0063-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free